NDANASALSPRAY, METERED
Approved
Jan 2022
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
3/8 — Basic
Drug data last refreshed 13h ago · AI intelligence enriched 2mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
RYALTRIS is a fixed-dose combination nasal spray containing olopatadine hydrochloride (a selective H1-receptor antagonist) and mometasone furoate (a corticosteroid) approved for allergic rhinitis. The dual mechanism addresses both the immediate allergic response and underlying inflammation. It represents a novel combination approach to nasal allergy management.
$0.001BPart D
Peak18.2 years to LOEEarly-stage revenue with minimal Part D penetration suggests significant growth runway; commercial team likely lean but expanding as awareness builds.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
RYALTRIS offers a unique career opportunity in a differentiated nasal allergy product with minimal linked external job postings, suggesting an emerging brand still building its internal team structure. The combination mechanism and early-stage commercial performance indicate roles in market development, managed care navigation, and field education will be critical to scaling prescriber adoption.
Brand Manager
Worked on RYALTRIS at Glenmark Pharms Ltd? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.